The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, New South Wales, Australia.
The University of Sydney, Faculty of Medicine and Health, School of Pharmacy, Sydney, New South Wales, Australia; NSW Poisons Information Center, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
J Am Med Dir Assoc. 2021 Jun;22(6):1206-1214.e5. doi: 10.1016/j.jamda.2020.12.035. Epub 2021 Feb 2.
To assess the prevalence and characteristics of psychotropic medication-related hospitalizations in older people.
Systematic review with meta-analysis.
Older adults (≥65 years of age) with psychotropic-related hospitalizations.
A search of published literature was performed in Medline, Embase, CINAHL, and Scopus from 2010 to March 2020. Three authors independently screened titles, abstracts, and full texts of relevant studies for relevance. Two authors independently extracted full text data, including characteristics, measures of causality, prevalence data, and performed quality assessment. A meta-analysis was conducted to estimate pooled prevalence and 95% confidence intervals (CIs) of psychotropic-related hospitalizations using random effects models. Heterogeneity was explored using subgroup analyses.
Of 815 potentially relevant studies, 11 were included in the final analysis. Five studies were cross-sectional studies, 5 were cohort studies, and 1 was a case control study. The majority of studies were rated as good quality. Psychotropic medications contributed to 2.1% (95% CI 1.2%-3.3%) of total hospitalizations and 11.3% (95% CI 8.2%-14.8%) of adverse drug event-related hospitalizations. The main psychotropic medications attributable to hospitalizations were antidepressants, hypnotics, sedatives, and antipsychotics.
Psychotropic medications are a significant contributor to hospitalizations in older adults. The risk of hospitalization was greatest for those taking antidepressants, antipsychotics, hypnotics, and sedatives. Future studies should aim to address specific medication subgroups and implement uniform adverse drug event-related classification systems to improve comparability across studies.
评估老年人中与精神药物相关的住院治疗的流行率和特征。
系统评价与荟萃分析。
有精神药物相关住院治疗的老年人(≥65 岁)。
对 2010 年至 2020 年 3 月期间在 Medline、Embase、CINAHL 和 Scopus 中发表的文献进行了搜索。三名作者独立筛选相关研究的标题、摘要和全文以确定其相关性。两名作者独立提取全文数据,包括特征、因果关系衡量标准、流行率数据,并进行质量评估。使用随机效应模型对荟萃分析进行了评估,以估计与精神药物相关的住院治疗的汇总流行率和 95%置信区间(CI)。使用亚组分析探索异质性。
在 815 项潜在相关研究中,有 11 项研究被纳入最终分析。其中 5 项为横断面研究,5 项为队列研究,1 项为病例对照研究。大多数研究的质量较高。精神药物治疗导致 2.1%(95%CI 1.2%-3.3%)的总住院治疗和 11.3%(95%CI 8.2%-14.8%)的药物不良反应相关住院治疗。导致住院治疗的主要精神药物为抗抑郁药、催眠药、镇静剂和抗精神病药。
精神药物治疗是老年人住院治疗的一个重要原因。服用抗抑郁药、抗精神病药、催眠药和镇静剂的患者住院风险最高。未来的研究应针对特定药物亚组,并实施统一的药物不良反应相关分类系统,以提高研究间的可比性。